To include your compound in the COVID-19 Resource Center, submit it here.

Adapalene 0: Phase III data

A double-blind Phase III trial in 503 patients ages >=12 with moderate to severe acne showed that once-daily 0.3% A/BPO met the co-primary endpoints of

Read the full 253 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE